19
Participants
Start Date
September 8, 2021
Primary Completion Date
November 13, 2021
Study Completion Date
November 13, 2021
GLPG4716
From Day 3 to Day 14, participants will receive GLPG4716 tablets once daily in fasted state. On Day 8 GLPG4716 will be administered in fed state.
Midazolam
On Days 1, 3 and 13, participants will receive a single oral dose of MDZ as an oral solution in fasted state.
Altasciences, Montreal
Lead Sponsor
Galapagos NV
INDUSTRY